Outset Medical Statistics
Total Valuation
Outset Medical has a market cap or net worth of $47.01 million. The enterprise value is $90.18 million.
Important Dates
The last earnings date was Wednesday, February 19, 2025, after market close.
| Earnings Date | Feb 19, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Outset Medical has 53.70 million shares outstanding. The number of shares has increased by 4.77% in one year.
| Current Share Class | 53.70M |
| Shares Outstanding | 53.70M |
| Shares Change (YoY) | +4.77% |
| Shares Change (QoQ) | +4.45% |
| Owned by Insiders (%) | 1.85% |
| Owned by Institutions (%) | 51.48% |
| Float | 26.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.40 |
| Forward PS | 0.39 |
| PB Ratio | 1.73 |
| P/TBV Ratio | 1.75 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.79 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.69, with a Debt / Equity ratio of 7.53.
| Current Ratio | 5.69 |
| Quick Ratio | 4.28 |
| Debt / Equity | 7.53 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.53 |
Financial Efficiency
Return on equity (ROE) is -170.97% and return on invested capital (ROIC) is -27.72%.
| Return on Equity (ROE) | -170.97% |
| Return on Assets (ROA) | -22.93% |
| Return on Invested Capital (ROIC) | -27.72% |
| Return on Capital Employed (ROCE) | -46.95% |
| Revenue Per Employee | $236,852 |
| Profits Per Employee | -$266,617 |
| Employee Count | 480 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 1.37 |
Taxes
In the past 12 months, Outset Medical has paid $491,000 in taxes.
| Income Tax | 491,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -73.87% in the last 52 weeks. The beta is 2.01, so Outset Medical's price volatility has been higher than the market average.
| Beta (5Y) | 2.01 |
| 52-Week Price Change | -73.87% |
| 50-Day Moving Average | 0.97 |
| 200-Day Moving Average | 1.79 |
| Relative Strength Index (RSI) | 49.89 |
| Average Volume (20 Days) | 974,116 |
Short Selling Information
The latest short interest is 9.08 million, so 16.91% of the outstanding shares have been sold short.
| Short Interest | 9.08M |
| Short Previous Month | 6.46M |
| Short % of Shares Out | 16.91% |
| Short % of Float | 34.85% |
| Short Ratio (days to cover) | 5.70 |
Income Statement
In the last 12 months, Outset Medical had revenue of $113.69 million and -$127.98 million in losses. Loss per share was -$2.46.
| Revenue | 113.69M |
| Gross Profit | 39.13M |
| Operating Income | -108.17M |
| Pretax Income | -158.67M |
| Net Income | -127.98M |
| EBITDA | -102.41M |
| EBIT | -108.17M |
| Loss Per Share | -$2.46 |
Full Income StatementBalance Sheet
The company has $158.69 million in cash and $201.86 million in debt, giving a net cash position of -$43.17 million or -$0.80 per share.
| Cash & Cash Equivalents | 158.69M |
| Total Debt | 201.86M |
| Net Cash | -43.17M |
| Net Cash Per Share | -$0.80 |
| Equity (Book Value) | 26.82M |
| Book Value Per Share | 0.51 |
| Working Capital | 212.84M |
Full Balance SheetCash Flow
| Operating Cash Flow | -116.30M |
| Capital Expenditures | n/a |
| Free Cash Flow | -116.30M |
| FCF Per Share | -$2.17 |
Full Cash Flow StatementMargins
Gross margin is 34.42%, with operating and profit margins of -95.15% and -112.57%.
| Gross Margin | 34.42% |
| Operating Margin | -95.15% |
| Pretax Margin | -112.13% |
| Profit Margin | -112.57% |
| EBITDA Margin | -90.08% |
| EBIT Margin | -95.15% |
| FCF Margin | n/a |
Dividends & Yields
Outset Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.77% |
| Shareholder Yield | -4.77% |
| Earnings Yield | -272.25% |
| FCF Yield | -247.41% |
Analyst Forecast
The average price target for Outset Medical is $4.00, which is 356.93% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.00 |
| Price Target Difference | 356.93% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 8.89% |
| EPS Growth Forecast (5Y) | -57.48% |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Outset Medical has an Altman Z-Score of -5.2 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.2 |
| Piotroski F-Score | 4 |